Published on 30 May 2024 on Market Watch
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
jumped more than 270% Thursday after the company said its experimental cancer drug outperformed...
NASDAQ.SMMT price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free